COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers

Coronavirus disease 2019 (COVID-19) appears to be an independent risk factor for stroke. We hypothesize that patients who develop stroke while hospitalized for severe COVID-19 will have higher inflammatory markers and distinct stroke imaging patterns compared with patients positive for COVID-19 with out-of-hospital stroke onset and milder or no COVID-19 symptoms. This is a retrospective case series of patients positive for COVID-19 on polymerase chain reaction testing with imaging-confirmed stroke treated within a large health care network in New York City and Long Island between March 14 and April 26, 2020. Clinical and laboratory data collected retrospectively included complete blood counts and creatinine, alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer levels. All CT and MR imaging studies were independently reviewed by 2 neuroradiologists who recorded stroke subtype and patterns of infarction and intracranial hemorrhage. Compared with patients with COVID-19 with outside-of-hospital stroke onset and milder or no COVID-19 symptoms ( = 45, 52.3%), patients with stroke already hospitalized for severe COVID-19 ( = 41, 47.7%) had significantly more frequent infarctions (95.1% versus 73.3%, = .006), with multivascular distributions (56.4% versus 33.3%, = .022) and associated hemorrhage (31.7% versus 4.4%, = .001). Patients with stroke admitted with more severe COVID-19 had significantly higher C-reactive protein and ferritin levels, elevated D-dimer levels, and more frequent lymphopenia and renal and hepatic injury (all,